There are more victims of the zombie apocalypse which according to some has already begun. A new victim according to Kait8.com died on June 14 Police in Waco, TX. Police arrested Michael Daniel (22 yo) and charged him animal cruelty from eating his family’s dog while the he was still alive. Michael was arrested after family his members called police to their home and said “Daniel assaulted people at home, chased a neighbor and started barking and growling.”
Witnesses also said Daniel grabbed his family’s dog, beat and strangled it, and started to eat it. He was actually tearing at the dog’s flesh with his teeth! Police found Daniel covered in blood on his face and clothes from the attack. The dog died from his wounds at the home.
Daniel is believed to have ingested a synthetic drug called “spice” or “K-2” sometime before the attack. Did you know these drugs are readily available everywhere in smoke shops across the country? These designer drugs creating a quick, intense high, followed by extreme paranoia and acute psychosis. The synthetic stimulants are commonly sold as plant fertilizer and marketed under names such as Ivory Wave. The two types of synthetic drugs are commonly referred to as “fake pot” and “bath salts.”
These drugs are responsible for a wave of zombie like behavior spreading over the world right now. The US Senate passed a synthetic drug ban titled H. R. 1254 which federally criminalizes the possession, distribution, and manufacture of synthetic cannabinoids (“fake marijuana”) and synthetic stimulants (“bath salts”). The measure has also already passed the House, and President Obama is expected to sign it sometime into law. Here is the bill so you can look it up to see where it is at in the process law http://thomas.loc.gov/cgi-bin/bdquery/z?d112:h.r.1254:
Why is it not a law yet????? How many more victims have to die or have their face ripped off before it becomes a law??
112th CONGRESS
1st Session
H. R. 1254
IN THE SENATE OF THE UNITED STATES
December 8, 2011
Received; read twice and referred to the Committee on the Judiciary
——————————————————————————–
AN ACT
To amend the Controlled Substances Act to place synthetic drugs in Schedule I.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ‘Synthetic Drug Control Act of 2011’.
SEC. 2. ADDITION OF SYNTHETIC DRUGS TO SCHEDULE I OF THE CONTROLLED SUBSTANCES ACT.
(a) Cannabimimetic Agents- Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended by adding at the end the following:
‘(d)(1) Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of cannabimimetic agents, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.
‘(2) In paragraph (1):
‘(A) The term ‘cannabimimetic agents’ means any substance that is a cannabinoid receptor type 1 (CB1 receptor) agonist as demonstrated by binding studies and functional assays within any of the following structural classes:
‘(i) 2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position of the phenolic ring by alkyl or alkenyl, whether or not substituted on the cyclohexyl ring to any extent.
‘(ii) 3-(1-naphthoyl)indole or 3-(1-naphthylmethane)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent.
‘(iii) 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted on the naphthoyl ring to any extent.
‘(iv) 1-(1-naphthylmethylene)indene by substitution of the 3-position of the indene ring, whether or not further substituted in the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent.
‘(v) 3-phenylacetylindole or 3-benzoylindole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the phenyl ring to any extent.
‘(B) Such term includes–
‘(i) 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497);
‘(ii) 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog);
‘(iii) 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678);
‘(iv) 1-butyl-3-(1-naphthoyl)indole (JWH-073);
‘(v) 1-hexyl-3-(1-naphthoyl)indole (JWH-019);
‘(vi) 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200);
‘(vii) 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250);
‘(viii) 1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081);
‘(ix) 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122);
‘(x) 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398);
‘(xi) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201);
‘(xii) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694);
‘(xiii) 1-pentyl-3-[(4-methoxy)-benzoyl]indole (SR-19 and RCS-4);
‘(xiv) 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (SR-18 and RCS-8); and
‘(xv) 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203).’.
(b) Other Drugs- Schedule I of section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended in subsection (c) by adding at the end the following:
‘(18) 4-methylmethcathinone (Mephedrone).
‘(19) 3,4-methylenedioxypyrovalerone (MDPV).
‘(20) 3,4-methylenedioxymethcathinone (methylone).
‘(21) Naphthylpyrovalerone (naphyrone).
‘(22) 4-fluoromethcathinone (flephedrone).
‘(23) 4-methoxymethcathinone (methedrone; Bk-PMMA).
‘(24) Ethcathinone (N-Ethylcathinone).
‘(25) 3,4-methylenedioxyethcathinone (ethylone).
‘(26) Beta-keto-N-methyl-3,4-benzodioxyolybutanamine (butylone).
‘(27) N,N-dimethylcathinone (metamfepramone).
‘(28) Alpha-pyrrolidinopropiophenone (alpha-PPP).
‘(29) 4-methoxy-alpha-pyrrolidinopropiophenone (MOPPP).
‘(30) 3,4-methylenedioxy-alphapyrrolidinopropiophenone (MDPPP).
‘(31) Alpha-pyrrolidinovalerophenone (alpha-PVP).
‘(32) 6,7-dihydro-5H-indeno-(5,6-d)-1,3-dioxol-6-amine) (MDAI).
‘(33) 3-fluoromethcathinone.
‘(34) 4’-Methyl-a-pyrrolidinobutiophenone (MPBP).
‘(35) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).
‘(36) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).
‘(37) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C).
‘(38) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I).
‘(39) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2).
‘(40) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4).
‘(41) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H).
‘(42) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N).
‘(43) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P).’.
SEC. 3. TEMPORARY SCHEDULING TO AVOID IMMINENT HAZARDS TO PUBLIC SAFETY EXPANSION.
Section 201(h)(2) of the Controlled Substances Act (21 U.S.C. 811(h)(2)) is amended–
(1) by striking ‘one year’ and inserting ‘2 years’; and
(2) by striking ‘six months’ and inserting ‘1 year’.
Passed the House of Representatives December 8, 2011.
Attest:
KAREN L. HAAS,
Clerk.
